{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:38:18Z","timestamp":1793147898253,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["714312"],"award-info":[{"award-number":["714312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1591-2","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T17:27:20Z","timestamp":1525368440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example"],"prefix":"10.1186","volume":"20","author":[{"given":"Debbie M.","family":"Boeters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette H. M.","family":"van der Helm-van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna W.","family":"van Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"1591_CR1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1591_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797\u2013808.","journal-title":"Ann Intern Med"},{"key":"1591_CR3","doi-asserted-by":"publisher","first-page":"e000318","DOI":"10.1136\/rmdopen-2016-000318","volume":"2","author":"K Raza","year":"2016","unstructured":"Raza K, Schwenzer A, Juarez M, Venables P, Filer A, Buckley CD, et al. Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis. RMD Open. 2016;2:e000318.","journal-title":"RMD Open"},{"key":"1591_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/rheumatology\/kew198","volume":"55","author":"LM De Winter","year":"2016","unstructured":"De Winter LM, Hansen WLJ, van Steenbergen HW, Geusens P, Lenaerts J, Somers K, et al. Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis. Rheumatol Oxf Engl. 2016;55:1431\u20136.","journal-title":"Rheumatol Oxf Engl"},{"key":"1591_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","volume":"75","author":"M Juarez","year":"2016","unstructured":"Juarez M, Bang H, Hammar F, Reimer U, Dyke B, Sahbudin I, et al. Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Ann Rheum Dis. 2016;75:1099\u2013107.","journal-title":"Ann Rheum Dis"},{"key":"1591_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VPK Nell","year":"2005","unstructured":"Nell VPK, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1731\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1591_CR7","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GMC, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011;108:17372\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/art.40237","volume":"69","author":"M-E Truchetet","year":"2017","unstructured":"Truchetet M-E, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, et al. Association of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR Cohort. Arthritis Rheumatol. 2017;69:2292\u2013302.","journal-title":"Arthritis Rheumatol"},{"key":"1591_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/annrheumdis-2015-208870","volume":"76","author":"S Ajeganova","year":"2017","unstructured":"Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafstr\u00f6m I, Toes REM, et al. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ann Rheum Dis. 2017;76:112\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"DPC Rooy de","year":"2011","unstructured":"de Rooy DPC, van der Linden MPM, Knevel R, Huizinga TWJ, Mil AHM van der H. Predicting arthritis outcomes\u2014what can be learned from the Leiden Early Arthritis Clinic? Rheumatology. 2011;50:93\u2013100.","journal-title":"Rheumatology"},{"key":"1591_CR11","doi-asserted-by":"publisher","first-page":"12023","DOI":"10.1038\/s41598-017-09657-5","volume":"7","author":"C Regueiro","year":"2017","unstructured":"Regueiro C, Nu\u00f1o L, Ortiz AM, Peiteado D, Villalba A, Pascual-Salcedo D, et al. Value of measuring anti-carbamylated protein antibodies for classification on early arthritis patients. Sci Rep. 2017;7:12023.","journal-title":"Sci Rep"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1591-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1591-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1591-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T11:51:00Z","timestamp":1589889060000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1591-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1591-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved under number P10.108 by the medical ethics committee of the Leiden University Medical Center, which is named Commissie Medische Ethiek. All patients signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"LAT is listed as an inventor on a patent on the detection of anti-CarP antibodies. The remaining authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}